Enhancing the solubility and masking the bitter taste of propiverine using crystalline complex formation

Abstract Context: Patient compliance can be reduced when bitter-tasting compounds, such as propiverine hydrochloride, are administered orally. Propiverine hydrochloride is an example of a drug with a bitter taste, used for the treatment of overactive bladders. Objective: This study tested whether propiverine free base palatability and aqueous solubility could be improved by crystalline complex formation. Materials and methods: We used 42 compounds, and found 9 new propiverine crystalline complexes. The properties and solubility of these complexes were studied using a range of techniques. A taste perception study was carried out using a taste sensor to evaluate the taste masking ability of the crystalline complex formation. Results: The melting points of the crystalline complexes were higher than that of propiverine. The dissolution rates of the crystalline complexes in aqueous buffer solution (pH 6.8) and in purified water were much faster than that of propiverine. Propiverine salicylic acid crystalline complex had substantially less bitterness than propiverine hydrochloride, which was extremely bitter. Discussion: The present findings indicated that crystalline complex formation provided an effective approach to enhancing propiverine solubility, and to masking its bitter taste. Conclusion: Crystalline complex formation represents a useful and valuable technique for the preparation of orally disintegrating tablets and improving patient compliance, even for substances with bitter tastes.

[1]  Orn Almarsson,et al.  Performance comparison of a co-crystal of carbamazepine with marketed product. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[2]  Ping Li,et al.  A Polymer Carrier System for Taste Masking of Macrolide Antibiotics , 1991, Pharmaceutical Research.

[3]  R. Davey,et al.  Making Co-crystals-The utility of ternary phase diagrams , 2007 .

[4]  Mitsuyoshi Okamoto,et al.  Bitterness evaluation of orally disintegrating famotidine tablets using a taste sensor , 2009 .

[5]  M. Kinoshita,et al.  Taste masking of propiverine hydrochloride by conversion to its free base. , 2012, Chemical & pharmaceutical bulletin.

[6]  Takahiro Uchida,et al.  The bitterness intensity of clarithromycin evaluated by a taste sensor. , 2003, Chemical & pharmaceutical bulletin.

[7]  Takahiro Uchida,et al.  A new method for evaluating the bitterness of medicines in development using a taste sensor and a disintegration testing apparatus. , 2010, Chemical & pharmaceutical bulletin.

[8]  Aeri Park,et al.  The salt-cocrystal continuum: the influence of crystal structure on ionization state. , 2007, Molecular pharmaceutics.

[9]  Hassan Almoazen,et al.  Investigation of Solubility and Dissolution of a Free Base and Two Different Salt Forms as a Function of pH , 2005, Pharmaceutical Research.

[10]  Jeanette T. Dunlap,et al.  Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids. , 2004, Journal of the American Chemical Society.

[11]  G. Salvioli,et al.  2-Hydroxypropyl-β-cyclodextrin complexation with ursodeoxycholic acid , 1995 .

[12]  N. Rodríguez-Hornedo,et al.  Cocrystals and Salts of Gabapentin: pH Dependent Cocrystal Stability and Solubility , 2009 .

[13]  Naír Rodríguez-Hornedo,et al.  Solubility Advantage of Pharmaceutical Cocrystals , 2009 .

[14]  Richard J. Bastin,et al.  Salt Selection and Optimisation Procedures for Pharmaceutical New Chemical Entities , 2000 .

[15]  Aeri Park,et al.  Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API , 2006, Pharmaceutical Research.

[16]  D. Good,et al.  Cocrystal Eutectic Constants and Prediction of Solubility Behavior , 2010 .

[17]  Naír Rodríguez-Hornedo,et al.  Understanding and Predicting the Effect of Cocrystal Components and pH on Cocrystal Solubility , 2009 .

[18]  R. Agarwal,et al.  Studies of Ion-Exchange Resin Complex of Chloroquine Phosphate , 2000, Drug development and industrial pharmacy.

[19]  Sekhar Surapaneni,et al.  The co-crystal approach to improve the exposure of a water-insoluble compound: AMG 517 sorbic acid co-crystal characterization and pharmacokinetics. , 2008, Journal of pharmaceutical sciences.

[20]  Antonio Carlos Pizzolitto,et al.  A nonstaining and tasteless hydrophobic salt of chlorhexidine. , 2011, Journal of pharmaceutical sciences.

[21]  Ashwini Nangia,et al.  Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals , 2011 .

[22]  Ashok R. Patel,et al.  Preparation and Evaluation of Taste Masked Famotidine Formulation Using Drug/β-cyclodextrin/Polymer Ternary Complexation Approach , 2008, AAPS PharmSciTech.

[23]  Sarah J. Nehm,et al.  Phase solubility diagrams of cocrystals are explained by solubility product and solution complexation , 2006 .

[24]  Naír Rodríguez-Hornedo,et al.  Effect of Micellar Solubilization on Cocrystal Solubility and Stability , 2010 .

[25]  Michael J Cima,et al.  High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. , 2004, Advanced drug delivery reviews.

[26]  V. Anand,et al.  Ion-exchange resins: carrying drug delivery forward. , 2001, Drug discovery today.

[27]  A. Bak,et al.  Physicochemical Properties of Pharmaceutical Co-Crystals: A Case Study of Ten AMG 517 Co-Crystals , 2008 .

[28]  Kiyoshi Toko,et al.  Advanced Taste Sensors Based on Artificial Lipids with Global Selectivity to Basic Taste Qualities and High Correlation to Sensory Scores , 2010, Sensors.

[29]  Abu T M Serajuddin,et al.  Salt formation to improve drug solubility. , 2007, Advanced drug delivery reviews.

[30]  Yoshiki Hayashi,et al.  Dissolution Improvement and the Mechanism of the Improvement from Cocrystallization of Poorly Water-soluble Compounds , 2008, Pharmaceutical Research.

[31]  L. Szente,et al.  Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.